University College Dublin

AngioDynamics launches RECOVER-AV trial to evaluate AlphaVac F18⁸⁵ System for acute, intermediate-risk PE in Europe, following successful APEX-AV study in the U.S. The trial aims to assess safety and efficacy, with primary endpoints focusing on RV/LV ratio reduction and Major Adverse Events incidence.

University College Dublin, An Coláiste Ollscoile, Baile Átha Cliath, features a logo with the text 'University College Dublin'.

HRB awards €12.4 million to 29 Investigator-Led Projects, including €2,154,914 to five UCD projects. Themes include patient-oriented, population health, and health service research. UCD's Dr Radka Fahey and Prof Alistair Nichol among recipients. HRB aims to address major health challenges and improve healthcare.

A study at St Vincent's University Hospital challenges the belief that weight loss medications like Ozempic, Wegovy, or Monjaro work solely by promoting satiety. The randomized controlled trial, led by Professor Donal O'Shea, found a strong relationship between the increase in metabolic activity caused by GLP-1 treatment and weight loss, with low metabolic activity prior to treatment showing the most benefit.